2005
DOI: 10.1007/s00540-004-0281-1
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of landiolol in attenuating hemodynamic responses to local epinephrine infiltration in patients undergoing vaginal total hysterectomy

Abstract: The present study suggests that landiolol 10 mg may be a more suitable dose than landiolol 5 mg to antagonize hyperdynamic states induced by local administration of epinephrine.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 9 publications
0
4
0
Order By: Relevance
“…Therefore, it is less likely to cause hypotension and can control heart rate while minimizing the effect on blood pressure in patients with anaphylactic shock. Since landiolol can suppress the hemodynamic effects of adrenaline, [ 17 , 18 ] it was administered in combination with the careful use of adrenaline to reduce myocardial oxygen consumption and maintain the myocardial oxygen supply–demand balance by suppressing tachycardia.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is less likely to cause hypotension and can control heart rate while minimizing the effect on blood pressure in patients with anaphylactic shock. Since landiolol can suppress the hemodynamic effects of adrenaline, [ 17 , 18 ] it was administered in combination with the careful use of adrenaline to reduce myocardial oxygen consumption and maintain the myocardial oxygen supply–demand balance by suppressing tachycardia.…”
Section: Discussionmentioning
confidence: 99%
“…Landiolol is a short-acting b1-selective blocker characterized by a short half-life (4 min) and good stability in continuous administration [4]. The drug has been used for treatment of perioperative tachyarrhythmia in Japan [5][6][7][8], and successful control of heart rate and conversion to sinus rhythm in patients with atrial fibrillation has also been achieved with landiolol [8]. A similar clinical course occurred in our patient with atrial flutter, with sinus rhythm obtained when arrhythmia was controlled by administration of landiolol.…”
Section: Discussionmentioning
confidence: 99%
“…Landiolol, an ultra-short-acting ␤ 1 -selective adrenoceptor antagonist, is now being widely used in Japan (6,7). It has a shorter plasma half-life of approximately 4 min and a higher cardioselectivity, with a potency ratio (␤ 1 /␤ 2 ) of 255, as compared with 9 min and 33, respectively, for esmolol (8 -10).…”
mentioning
confidence: 99%